Literature DB >> 23443230

Canadian trends in liver cancer: a brief clinical and epidemiologic overview.

P De1, D Dryer, M C Otterstatter, R Semenciw.   

Abstract

Although primary liver cancer is rare, its incidence rate has been rising quickly in Canada, more than tripling since the early 1980s. This cancer is more common in men than women, and the age-specific incidence rates in men have been increasing significantly in all age groups from 40 years of age onward. The death rate has followed a similar upward trajectory, in part because of the low 5-year survival rate of 18% in both sexes. Infection with the hepatitis B or C virus continues to be the most common risk factor, but other factors may also play a role. Risk reduction strategies, such as viral hepatitis screening, have been recommended in other countries and warrant consideration in Canada as part of a coordinated strategy of disease prevention and control.

Entities:  

Keywords:  Liver cancer; prevention; risk factors; surveillance; trends

Year:  2013        PMID: 23443230      PMCID: PMC3557341          DOI: 10.3747/co.20.1190

Source DB:  PubMed          Journal:  Curr Oncol        ISSN: 1198-0052            Impact factor:   3.677


  26 in total

Review 1.  Hepatocellular carcinoma: the need for progress.

Authors:  Melanie B Thomas; Andrew X Zhu
Journal:  J Clin Oncol       Date:  2005-05-01       Impact factor: 44.544

Review 2.  Review article: the changing epidemiology of hepatocellular carcinoma in Canada.

Authors:  Z Dyer; K Peltekian; S Veldhuyzen van Zanten
Journal:  Aliment Pharmacol Ther       Date:  2005-07-01       Impact factor: 8.171

Review 3.  Hepatitis B virus infection.

Authors:  W M Lee
Journal:  N Engl J Med       Date:  1997-12-11       Impact factor: 91.245

4.  Alcohol, tobacco and obesity are synergistic risk factors for hepatocellular carcinoma.

Authors:  Jorge A Marrero; Robert J Fontana; Sherry Fu; Hari S Conjeevaram; Grace L Su; Anna S Lok
Journal:  J Hepatol       Date:  2005-02       Impact factor: 25.083

5.  Alcohol consumption as a major risk factor for the rise in liver cancer mortality rates in Japanese men.

Authors:  K Makimoto; S Higuchi
Journal:  Int J Epidemiol       Date:  1999-02       Impact factor: 7.196

6.  Recommendations for the identification of chronic hepatitis C virus infection among persons born during 1945-1965.

Authors:  Bryce D Smith; Rebecca L Morgan; Geoff A Beckett; Yngve Falck-Ytter; Deborah Holtzman; Chong-Gee Teo; Amy Jewett; Brittney Baack; David B Rein; Nita Patel; Miriam Alter; Anthony Yartel; John W Ward
Journal:  MMWR Recomm Rep       Date:  2012-08-17

Review 7.  Obesity and hepatocellular carcinoma.

Authors:  Stephen H Caldwell; Deborah M Crespo; Hyon Scott Kang; Abdullah M S Al-Osaimi
Journal:  Gastroenterology       Date:  2004-11       Impact factor: 22.682

8.  Natural history of chronic hepatitis B virus infection in adults with emphasis on the occurrence of cirrhosis and hepatocellular carcinoma.

Authors:  C M Chu
Journal:  J Gastroenterol Hepatol       Date:  2000-05       Impact factor: 4.029

9.  Cigarette smoking and primary liver cancer: a population-based case-control study in US men.

Authors:  Kangmin Zhu; Cynthia Moriarty; Lee S Caplan; Robert S Levine
Journal:  Cancer Causes Control       Date:  2007-02-10       Impact factor: 2.506

Review 10.  The association between diabetes and hepatocellular carcinoma: a systematic review of epidemiologic evidence.

Authors:  Hashem B El-Serag; Howard Hampel; Fariba Javadi
Journal:  Clin Gastroenterol Hepatol       Date:  2006-03       Impact factor: 11.382

View more
  6 in total

1.  Hospital stays for hepatitis B or C virus infection or primary liver cancer among immigrants: a census-linked population-based cohort study.

Authors:  Edward Ng; Robert P Myers; Doug Manuel; Claudia Sanmartin
Journal:  CMAJ Open       Date:  2016-04-28

2.  Effect of sorafenib starting dose and dose intensity on survival in patients with hepatocellular carcinoma: Results from a Canadian Multicenter Database.

Authors:  Mohammed A Alghamdi; Carla P Amaro; Richard Lee-Ying; Hao-Wen Sim; Haider Samwi; Kelvin K Chan; Jennifer J Knox; Yoo-Joung Ko; Mina Swiha; Eugene Batuyong; Adriana Romagnino; Winson Y Cheung; Vincent C Tam
Journal:  Cancer Med       Date:  2020-06-11       Impact factor: 4.452

3.  Disease burden of liver cancer in China from 1997 to 2016: an observational study based on the Global Burden of Diseases.

Authors:  Cheng Ding; Xiaofang Fu; Yuqing Zhou; Xiaoxiao Liu; Jie Wu; Chenyang Huang; Min Deng; Yiping Li; Lanjuan Li; Shigui Yang
Journal:  BMJ Open       Date:  2019-04-23       Impact factor: 2.692

4.  Criteria to define rare diseases and orphan drugs: a systematic review protocol.

Authors:  Ghada Mohammed Abozaid; Katie Kerr; Amy McKnight; Hussain A Al-Omar
Journal:  BMJ Open       Date:  2022-07-29       Impact factor: 3.006

5.  Trends in incidence, mortality, and survival for kidney cancer in Canada, 1986-2007.

Authors:  Prithwish De; Michael C Otterstatter; Robert Semenciw; Larry F Ellison; Loraine D Marrett; Dagny Dryer
Journal:  Cancer Causes Control       Date:  2014-07-18       Impact factor: 2.506

6.  Preliminary evaluation of alpha-emitting radioembolization in animal models of hepatocellular carcinoma.

Authors:  Yong Du; Angel Cortez; Anders Josefsson; Mohammadreza Zarisfi; Rebecca Krimins; Eleni Liapi; Jessie R Nedrow
Journal:  PLoS One       Date:  2022-01-21       Impact factor: 3.240

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.